£N4P – ShareSoc presentation by CEO Nigel Theobald on 8th November 2017

http://www.piworld.co.uk/2017/11/11/n4-pharma-n4p-presentation-at-sharesoc-growth-seminar-november-2017/

c. 30 mins

Introduction – 00:20
Business model – 01:19
The lead products:
1. Sidenafil MR (Viagra) – 02:13
Bringing it to market – 7:58
2. Nuvec (cancer treatment): Silica nanoparticles vaccine delivery system – 08:58
Size of the opportunity – 12: 50
Route to market – 14:20
Other applications – 15:33
Summary – 16:25

Q&A
Why is your product superior compared to Zando & Pfizer’s? 18:00
Silica particles – how does it work? – 20:39
How much more cash will you need to generate revenue? – 22:13
What are challenges and hooks for future marketing partners? – 23:49
Do you need regulatory approval? – 27:25
If you fund phase III yourselves, what royalty would you expect? – 28:01
Does the portfolio include any other products? – 28:55

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here